SPADIShoulder Pain and Disability Index
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
The minimal clinically important difference has been reported to be 18 points.9 Those included were females and males aged 18 years or higher with SPADI a$?18 points who gave written informed consent.
In our study, the SPADI questionnaire was completed by all patients, which synchronously assess pain and functionality (11).
The SPADI is a 100-point, 13-item, self-administered questionnaire, divided into 2 subscales: a 5-item pain subscale and an 8-item disability subscale.
Indipendentemente dal gruppo di trattamento, i pazienti che hanno ricevuto un trattamento aggiuntivo hanno riportato un valore medio alla SPADI superiore agli altri sia all'inizio (52[+ or -]20) che ad 1 anno di follow-up (40,4[+ or -]25).
The outcome was measured using the Shoulder Pain and Disability Index (SPADI) and the results were significant after 15 treatments with a decrease in SPADI of 44 points, a measure that was still present at 6 months after the conclusion of the treatments.
(106) Fabio Spadi, The Bridge on the Strait of Messina: "'Lowering'" the Right of Innocent Passage?, 50 INT'L & COMP.
At 22 weeks, the active group demonstrated a statistically significant advantage compared with the placebo group in one primary measure; the Shoulder Pain and Disability Index (SPADI).